Imprint

On [date], RareSight AG has been renamed to Vivarus Diagnostics AG after internal alignment for fundraising.

​

This renaming has been carried out in accordance with ... . It constitutes a change in name only. The legal entity continues uninterrupted, and all assets, liabilities, rights, and obligations remain unchanged.

​

​

On April 23rd, RareSight GmbH has been transformed into RareSight AG to better prepare for future funding rounds.

​

This conversion has been carried out in accordance with the Swiss Merger Act (FusG). It constitutes a change in legal form only. The legal entity continues uninterrupted, and all assets, liabilities, rights, and obligations remain unchanged.